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Tooth resorption is a common sequela of injury or
irritation of the periodontal ligament and/or tooth
pulp. The course of resorption involves an elabo-
rate interaction among inflammatory cells, resorb-
ing cells, and hard tissue structures.1 Dental hard
tissues (cementum, dentin, enamel) do not nor-
mally undergo resorption. When resorption of
teeth is observed, it is usually the result of trauma,
replantation therapy, chronic inflammation of the
pulp and/or periodontal tissues, induced pressure
in periodontal ligaments associated with ortho-
dontic tooth movement, tumors, or tooth erup-
tion, or chemical irritation by bleaching agents or
other irritants.2,3
Resorption on the external root surface usually
accompanies simultaneous reactions within the
alveolar bone; the process of tooth resorption is
considered to be similar to that of bone resorp-
tion. Resorption of alveolar bone occurs as a result
of local inflammation and as part of life-long re-
modeling of the jaws.2 Resorption is primarily by
osteoclasts,4 but other cells, such as macrophages5
and monocytes,6 have been reported to possess
bone-resorbing activity. Osteoclasts resorb bone
by releasing demineralizing agents and degrada-
tive enzymes into Howship’s lacunae under the
ruffled border, and then ingest the bone degrada-
tion products by phagocytosis.7 Osteoclasts also
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ORIGINAL ARTICLE
have an important role in the inflammatory re-
sponse to infection, as seen in resorption of ne-
crotic bone in osteomyelitis8 and root and bone
resorption of teeth with pulp necrosis and/or 
infection.9
To inhibit osteoclastic activity, therapeutic
agents such as calcium hydroxide,10 fluoride,11
dexamethasone,12 calcitonin,13 antibiotics,14 cor-
ticosteroids,14 and bisphosphonates15 have been
used in dental practice. Strontium ranelate (SR)
(5-[bis(carboxymethyl)amino]-2-carboxy-4-
cyano-3-thiophenacetic acid distrontium salt) is
composed of an organic moiety (ranelic acid)
and two atoms of stable strontium. Ranelic acid
was chosen as the anion for the strontium salt
from 26 other candidates because the resulting
salt presented the most suitable physicochemical
(e.g. percentage of strontium, solubility, no chelat-
ing properties, stability) and pharmacokinetic (e.g.
bioavailability, exposure to strontium) character-
istics for a therapeutic agent.16 It has a dual mode
of action, both increasing bone formation and
decreasing bone resorption, which rebalances
bone turnover in favor of bone formation and
increases bone strength.17 Therefore, it is possi-
ble that SR can be used for the treatment of tooth
resorption.
Based on the anti-osteoclastic activity of SR, the
use of this drug in the treatment of dental trauma
is promising. However, for this purpose, SR must
be biocompatible with periodontal tissue. Before
testing this drug in vivo, the aim of this study was
to analyze SR cytotoxicity in human periodontal
ligament fibroblasts (PDL cells) in culture.
Methods
Primary culture of human PDL cells
PDL cells were obtained from fully erupted clini-
cally healthy third molar teeth extracted for ortho-
dontic purposes. Scaling and root planning were
performed before extraction. The teeth were ex-
tracted as atraumatically as possible and washed
twice in sterile saline solution to eliminate residual
blood. Periodontal ligament tissues, attached to
the middle third of the root surface only, were
scraped with a #15 scalpel using aseptic techniques,
and then transferred to culture medium.
The periodontal ligament tissue samples were
cut into 1–2-mm3 pieces, and then washed twice
with HBSS (Hank’s buffered salt solution).
Thereafter, the biopsies were placed in tissue cul-
ture flasks (25 cm2). The explants were incubated
with culture medium consisting of Dulbecco’s
Modified Eagle’s Medium (DMEM; Sigma, St Louis,
MO, USA), 10 mL HEPES, 4.5 g/L glucose, 3.7 g/L
NaHCO3, 100 U/mL penicillin, 100 mg/mL strep-
tomycin, and 2.5 mg/mL amphotericin (all from
Biochrom KG, Berlin, Germany), supplemented
with 10% heat-inactivated fetal bovine serum (FBS;
Pan Systems, Aidenbach, Germany). Cells were
grown at 37°C in a humidified atmosphere of 5%
carbon dioxide in air. The culture medium was
renewed twice weekly until the cells reached con-
fluence. For subcultivation, cells were detached
from the culture flasks with 0.25% trypsin/EDTA
solution (Sigma) for 3–5 minutes. The seventh
passage of PDL cells was used in the experiment
to achieve their maximum proliferative potential
and homogeneity. All tissue manipulations were
done under a sterile class I laminar airflow cabinet.
Exposure of PDL cells to different
concentrations of SR
The cytotoxicity of 20, 10, 5 and 2.5 mg/mL SR
(Protelos; Servier Laboratories, Paris, France) was
measured in vitro. The experimental groups were:
G1 (control), cultures grown on fresh DMEM and
10% FBS; G2, DMEM containing 20 mg/mL SR;
G3, DMEM containing 10 mg/mL SR; G4, DMEM
containing 5 mg/mL SR; and G5, DMEM contain-
ing 2.5 mg/mL SR. The immediate or short-term
response and long-term survival that measured the
retention of the self-renewal capacity of the cells
were analyzed.
Short-term assay (cell viability)
A total of 1×103 cells were plated on 35-mm diam-
eter petri dishes. Three days later, the culture me-
dium was exchanged for medium that contained
SR solution (G2–G5), while the control cultures
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(G1) received fresh medium. The medium inside
the dishes was discarded and replaced by solutions
diluted in fresh DMEM containing 10% FBS. After 1,
6, 12 and 24 hours, the cells of five dishes per group
were counted, and viability curves were plotted.
Long-term assay (cell survival, cell growth)
A total of 1×103 cells were plated on 35-mm diam-
eter petri dishes. After 6 hours, when the cells were
all attached, the culture medium was exchanged
for medium that contained SR solution (G2–G5),
while the control cultures (G1) received fresh
DMEM. The attached cells were harvested from
the dishes 2, 4, 6 and 8 days after seeding, using
a 0.25% trypsin solution (Sigma). The cells of five
dishes per group in suspension were then counted
and growth curves were plotted. Maintenance of
cell viability was obtained by exchanging half 
of the culture medium with fresh DMEM every
other day.
Viability and cell growth curves
The cell number was determined by counting the
viable cells in a hemocytometer using the trypan
blue dye-exclusion assay. For each period, cells
from five dishes of each group were harvested using
0.25% trypsin solution, and these cells in sus-
pension were counted under a phase-inverted
microscope (TMS; Nikon, Tokyo, Japan) with 
a hemocytometer at 200× magnification. The
number of viable cells harvested from each petri
dish was obtained by the following equation:
UC × D × 104/nSQ, where UC is the unstained
cell count (viable cells), D is the dilution of the cell
suspension, and nSQ is the number of counted
squares in the hemocytometer. The viable percent-
age of the cell population in each petri dish was
obtained using the following equation: UC/TC ×
100, where UC is the unstained cell count (viable
cells) and TC is the total cell count (stained plus
unstained cells).
Statistical analysis
Statistical analysis was accomplished using one-
way ANOVA complemented by Tukey’s test. The
level of significance was 5% (p < 0.05).
Results
The morphologic characteristics of the human PDL
cells in the presence of SR at 8 days are shown in
the Figure.
The mean percentage cell viability in the short-
term assay is shown in Table 1. Control cells (G1)
had stable cell viability of ∼99% in the first 24
hours. PDL cells treated with 20 mg/mL SR (G2)
presented a significantly smaller percentage cell
viability than that in the other groups after 6 hours
(p < 0.05). However, there was no significant dif-
ference between G1, G3, G4 and G5. At 12 and
24 hours, G5 presented a similar cell viability to
the control cells (G1).
The mean numbers of viable cells in the long-
term assay are shown in Table 2. At 2 days, there
was no statistically significant difference between
the groups (p > 0.05). At 4, 6 and 8 days, controls
(G1), cells treated with 5 mg/mL SR (G4) and
2.5 mg/mL SR (G5) showed an increase in cell
numbers.
Discussion
Toxicity testing of dental materials can be assessed
either in vitro or in vivo. In vitro testing is accepted
as a routine method for establishing cytotoxicity
of dental materials.18 When using in vitro meth-
ods, one can use established permanent cell lines
such as HeLa or L929 cells, or primary cells,
mainly oral fibroblasts, to test the dental mate-
rials.19 Cells derived from a primary culture are
distinguished by the fact that they have been cul-
tured for the first time. Therefore, they are charac-
terized, much like their original tissue, by a diploid
set of chromosomes, a largely unchanged meta-
bolic status, and a high degree of differentiation.
In contrast, established cell lines are morpholog-
ically and physiologically more homogeneous,
but because they have been passaged many
times, they have lost the karyotype of their origi-
nal tissue. The heterogeneity of primary cultures,
which reflects different stages of physiologic
aging, is much better suited to mimic the in vivo
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situation than the homogeneity of established
cell lines. Another important factor in this con-
text is the selection of the cell type best suited for
simulating the in vivo situation. Human uterine
carcinoma cells or sarcoma fibroblasts from
mice do not optimally simulate the cells found
in the human oral cavity.20 Therefore, a primary
culture of human PDL fibroblasts was used in this
study as target cells. These cells were obtained from
clinically healthy, extracted third molar teeth.
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Figure. Phase-inverted photomicrographs of PDL cells at 
8 days: (A) controls (GI); (B) cells treated with 20 mg/mL
SR (G2); (C) cells treated with 10 mg/mL SR (G3); (D) cells
treated with 5 mg/mL SR (G4); (E) cells treated with
2.5 mg/mL SR (G5).
Table 1. Percentage cell viability in the short-term assay*
Group Total (n) 1 hr 6 hr 12 hr 24 hr
1 (Control) 5 99.50 ± 0.5a 99.25 ± 0.9a 99.25 ± 0.9a 99.25 ± 0.5a
2 (20% SR) 5 99.25 ± 0.9a 90.00 ± 4.0b 75.00 ± 1.6c 58.75 ± 4.7b
3 (10% SR) 5 99.25 ± 0.5a 98.00 ± 0.8a 85.00 ± 4.0d 70.00 ± 1.6c
4 (5% SR) 5 99.50 ± 0.5a 99.25 ± 0.9a 93.75 ± 2.6a 88.00 ± 2.4d
5 (2.5% SR) 5 99.50 ± 0.5a 99.50 ± 0.5a 98.00 ± 0.8a 95.00 ± 0.8a
*Data presented as mean ± standard deviation. The same superscript letters indicate statistically nonsignificant values (p > 0.05).
We chose the trypan blue exclusion staining
technique because it is quick, easily performed,
and distinctively differentiates nonviable from
viable cells. However, the health of the viable cells
and their ability to proliferate cannot be deter-
mined from this technique. We simply aimed to
investigate the effects of experimental solutions
on the viability of PDL cells.
Bacteria and bacterial products in the root canal
act as stimulating factors of inflammatory root
resorption. To date, calcium hydroxide10 and leder-
mix14 (a drug combining tetracycline and cortico-
steroids) have been used as intracanal medication
to arrest this process.
Previous studies have indicated that inflam-
matory resorption and ankylosis, which are fre-
quent sequelae after delayed tooth replantation,
can be greatly reduced by treating the root surface
with fluoride.11,21 Fluorides induce the formation
of fluorapatite crystals over the radicular surface,
which inhibits the action of osteoclasts and thus
reduces the incidence of resorption. Similar to fluo-
ride, bisphosphonates are used for the treatment
of osteoporosis. They inhibit osteoclast activity
during bone resorption by binding to hydroxyap-
atite in bone, mainly in the surfaces affected by
osteoclastic resorption.22
Several studies have shown favorable effects
of topical or systemic antibiotics in avoiding root
resorption.23–26 The use of systemic penicillin
after an avulsion injury has been recommended
to decrease the occurrence of resorption com-
plications.23 Cvek et al24 reported decreased root
resorption after topical treatment of teeth with
doxycycline before replantation, and suggested
that the elimination of microorganisms from the
root surface might decrease the frequency of anky-
losis in replanted teeth. Additionally, systemic
tetracycline treatment has been found to result in
better root healing than systemic amoxicillin in
replacement resorption.25,26
In the meantime, other therapeutic agents such
as dexamethasone (anti-inflammatory drug),12
calcitonin (hormone),13 enamel matrix protein
(emdogain),27 and chlorophyllin (antioxidant)28
have been used in dental practice to inhibit osteo-
clastic activity.
SR has a dual effect on bone metabolism. 
In vitro studies have suggested that SR enhances
osteoblastic cell replication and activity.29 Simul-
taneously, SR dose dependently decreases preosteo-
clast differentiation and osteoclastic activity.29–31
Some recent studies have suggested that interac-
tion of strontium with the calcium-sensing recep-
tor is one of the explanations for its mechanism
of action.32 This potential mechanism of action
and other possible modulations of bone turnover
remain to be fully elucidated.
The aim of the present study was to analyze
SR cytotoxicity in vitro using cell cultures that origi-
nated from human PDL cells. The SR concentra-
tions of 20, 10, 5 and 2.5 mg/mL were based on
the results observed in a pilot study in which con-
centrations > 20 mg/mL showed extreme cytotox-
icity. In the short-term assay, the viability of cells
treated with 2.5 mg/mL SR was similar to that of
control cells. Additionally, cells did not lose their
ability to enter the cell cycle, and they retained
their proliferation activity, as demonstrated by the
long-term assay.
Based on our results, we suggest that adminis-
tration of SR at appropriate concentrations might
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Table 2. Number of viable cells in the long-term assay*
Group Total (n) 2 d 4 d 6 d 8 d
1 (Control) 5 4.0 × 103 ± 0.5a 5.0 × 103 ± 0.5a 6.4 × 103 ± 1.0a 7.0 × 103 ± 1.0a
2 (20% SR) 5 2.5 × 103 ± 0.5a 1.5 × 103 ± 0.5b 1.3 × 103 ± 0.2b 0.1 × 103 ± 0.2b
3 (10% SR) 5 3.0 × 103 ± 1.0a 2.3 × 103 ± 1.0b 2.0 × 103 ± 0.5b 1.5 × 103 ± 0.5b
4 (5% SR) 5 4.0 × 103 ± 1.0a 5.5 × 103 ± 1.0a 6.1 × 103 ± 0.5a 6.5 × 103 ± 0.5a
5 (2.5% SR) 5 4.3 × 103 ± 1.5a 4.8 × 103 ± 0.2a 6.3 × 103 ± 0.2a 6.8 × 103 ± 0.2a
*Data presented as mean ± standard deviation. The same superscript letters indicate statistically nonsignificant values (p > 0.05).
be non-cytotoxic to PDL cells and should be used
for treating tooth resorption. Besides, the meas-
urement of cytotoxicity, as carried out in the pres-
ent study, is a purely cellular event. Thus, it does
not reflect in vivo situations that have complex
pharmacokinetics of drug exposure. New studies,
using animals as well as human subjects, are
needed to investigate the treatment and control of
tooth resorption.
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